Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID-19 severe or critically meta-analysis

Davoudi-Monfared, 2020
 
IRCT20100228003449N2
RCTinterferonstandard of careCOVID-19 severe or criticallyhigh
46/46 no results
    Yekaninejad, 2020
     
    IRCT20100228003449N2
    RCTinterferonstandard of careCOVID-19 severe or criticallysome concern
    33/33 conclusif
    • demonstrated 2.4-fold increase in clinical improvement (time to event analysis only) (PE) with a moderate degree of certainty due to some concern in risk of bias

    PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
    Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).